Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 214

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Of sound mind and body: depression, disease, and accelerated aging

Open access
M. Wolkowitz, Owen, I. Reus, Victor, H. Mellon, Synthia · 2011 · Dialogues in Clinical Neuroscience

Abstract

Major depressive disorder (MDD) is associated with a high rate of developing serious medical comorbidities such as cardiovascular disease, stroke, dementia, osteoporosis, diabetes, and the metabolic syndrome. These are conditions that typically occur late in life, and it has been suggested that MDD may be associated with "accelerated aging." We review several moderators and mediators that may accompany MDD and that may give rise to these comorbid medical conditions. We first review the moderating effects of psychological styles of coping, genetic predisposition, and epigenetic modifications (eg, secondary to childhood adversity). We then focus on several interlinked mediators occurring in MDD (or at least in subtypes of MDD) that may contribute to the medical comorbidity burden and to accelerated aging: limbic-hypothalamic-pituitary-adrenal axis alterations, diminution in glucocorticoid receptor function, altered glucose tolerance and insulin sensitivity, excitotoxicity, increases in intracellular calcium, oxidative stress, a proinflammatory milieu, lowered levels of "counter-regulatory" neurosteroids (such as allopregnanolone and dehydroepiandrosterone), diminished neurotrophic activity, and accelerated cell aging, manifest as alterations in telomerase activity and as shortening of telomeres, which can lead to apoptosis and cell death. In this model, MDD is characterized by a surfeit of potentially destructive mediators and an insufficiency of protective or restorative ones. These factors interact in increasing the likelihood of physical disease and of accelerated aging at the cellular level. We conclude with suggestions for novel mechanism-based therapeutics based on these mediators.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31887/dcns.2011.13.1/owolkowitz

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 99

  1. 10.1016/S0378-5122(02)00012-9 · DOI · Paper page
  2. 10.3109/10401230701653377 · doi:10.3109/10401230701653377
  3. 10.1016/j.biopsych.2005.05.001 · DOI · Paper page
  4. 10.1001/archinte.160.12.1761 · DOI · Paper page
  5. 10.1080/15622970701875601 · DOI
  6. 10.14310/horm.2002.1217 · DOI · Paper page
  7. 10.3109/15622970109026799 · DOI
  8. SelyeH.The Stress of Life. New York, NY: McGraw-Hill.1956
  9. 10.1016/S0893-133X(99)00129-3 · DOI · Paper page
  10. 10.1073/pnas.97.1.325 · DOI · Paper page
  11. 10.1016/j.yfrne.2008.11.002 · DOI · Paper page
  12. 10.1176/appi.ajp.160.9.1554 · DOI · Paper page
  13. 10.1037/0022-3514.50.5.992 · DOI · Paper page
  14. 10.1023/A:1010630801589 · DOI
  15. 10.1073/pnas.0914568107 · DOI
  16. 10.1037/0022-3514.95.1.197 · DOI · Paper page
  17. 10.1001/archpsyc.1988.01800350021003 · DOI · Paper page
  18. 10.1016/j.jad.2003.12.013 · DOI · Paper page
  19. 10.1590/S1516-44462008000100012 · DOI · Paper page
  20. 10.1002/syn.20637 · DOI
  21. BarnesSK.OzanneSE.Pathways linking the early environment to longterm health and lifespan.Prog Biophys Mol Biol. In press.
  22. 10.1016/j.brainresbull.2005.09.015 · DOI
  23. 10.1016/j.biopsych.2009.08.014 · DOI · Paper page
  24. 10.1038/nn1276 · DOI · Paper page
  25. 10.1176/appi.ajp.2009.10030434 · DOI · Paper page
  26. 10.1385/ENDO:28:3:263 · DOI
  27. 10.1097/YCO.0b013e32833d16c1 · DOI
  28. 10.1523/JNEUROSCI.4214-09.2010 · DOI · Paper page
  29. KargK.BurmeisterM.SheddenK.SenS.The Serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.Arch Gen Psychiatry. In press.
  30. 10.1016/j.biopsych.2005.10.026 · DOI · Paper page
  31. 10.1016/j.biopsych.2006.11.033 · DOI · Paper page
  32. MillerAH.Letter to the Editor Re: An inflammatory review of glucocorticoids in the CNS. Sorrells SF, Sapolsky RM.Brain Behavior Immun.200721259272988989; author reply 990.
  33. 10.1016/j.bbi.2006.11.006 · DOI · Paper page
  34. 10.1001/archpsyc.1987.01800210013002 · DOI
  35. 10.1176/ajp.152.2.265 · DOI
  36. BelanoffJ.SchatzbergAF.Glucocorticoid antagonists.Neuropsychopharmacology.200023S56
  37. 10.1097/00006842-199909000-00011 · DOI · Paper page
  38. 10.1002/14651858.CD005168.pub2 · DOI
  39. 10.1016/0166-2236(95)93942-Q · DOI · Paper page
  40. 10.1111/j.1749-6632.2009.04980.x · DOI · Paper page
  41. 10.1016/0165-1781(85)90088-5 · DOI
  42. 10.1073/pnas.95.6.3239 · DOI · Paper page
  43. 10.1016/S0006-3223(98)00070-5 · DOI
  44. 10.1159/000156467 · DOI · Paper page
  45. 10.1111/j.1582-4934.2008.00493.x · DOI
  46. 10.2174/156720507783018262 · DOI
  47. 10.1016/S0006-3223(98)00328-X · DOI · Paper page
  48. 10.1080/15622970310029901 · DOI
  49. 10.1016/S0074-7742(01)46065-X · DOI · Paper page
  50. 10.1677/joe.0.1580121 · DOI
  51. 10.1016/0306-4522(94)90330-1 · DOI · Paper page
  52. 10.1172/JCI119261 · DOI
  53. 10.1016/j.biopsycho.2005.02.007 · DOI
  54. 10.1055/s-0029-1237361 · DOI
  55. 10.1097/00006842-200203000-00010 · DOI · Paper page
  56. 10.1016/j.psyneuen.2006.11.009 · DOI · Paper page
  57. de LeonMJ.McRaeT.RusinekH.et al.Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.J Clin Endocrinol Metab.199782325132599329348
  58. 10.1517/14656566.7.10.1305 · DOI
  59. 10.1016/j.neurobiolaging.2005.09.004 · DOI
  60. 10.1007/s00424-009-0721-8 · DOI
  61. 10.1161/01.CIR.0000163550.70487.0B · DOI · Paper page
  62. 10.1038/oby.2010.22 · DOI · Paper page
  63. 10.1093/jn/136.12.3022 · DOI · Paper page
  64. 10.1111/j.1749-6632.2008.03966.x · DOI · Paper page
  65. 10.1016/j.yjmcc.2006.08.005 · DOI
  66. 10.1016/S0079-6123(07)63020-9 · DOI · Paper page
  67. 10.1111/j.1365-2796.2007.01890.x · DOI · Paper page
  68. 10.1016/j.jpsychires.2005.01.009 · DOI
  69. 10.1007/s11064-005-6967-4 · DOI
  70. 10.1097/01.psy.0000195780.37277.2a · DOI · Paper page
  71. 10.1111/j.1440-1797.2006.00697.x · DOI
  72. 10.1002/pmic.200300924 · DOI
  73. 10.1038/sj.mp.4002075 · DOI · Paper page
  74. 10.1016/S0006-3223(01)01083-6 · DOI · Paper page
  75. 10.3109/15622971003611319 · DOI · Paper page
  76. 10.1038/npp.2010.114 · DOI · Paper page
  77. 10.1016/j.bbr.2009.03.040 · DOI
  78. 10.1097/00001756-200405190-00016 · DOI
  79. 10.1523/JNEUROSCI.22-24-10710.2002 · DOI
  80. 10.1007/s00125-007-0706-0 · DOI
  81. 10.1038/nm1006-1133 · DOI · Paper page
  82. 10.1097/YPG.0b013e32808374f6 · DOI
  83. 10.18632/aging.100007 · DOI · Paper page
  84. 10.4049/jimmunol.179.6.4249 · DOI · Paper page
  85. WolkowitzOM.MellonSH.EpelES.et al.Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.Mol Psychiatry. In press.2011
  86. 10.1016/j.arr.2010.03.002 · DOI
  87. 10.1602/neurorx.1.1.111 · DOI
  88. 10.1111/j.1742-4658.2005.04677.x · DOI
  89. 10.1007/s11011-008-9118-1 · DOI · Paper page
  90. 10.1038/nrd2462 · DOI · Paper page
  91. 10.1002/hup.186 · DOI
  92. 10.2174/187152809789352221 · DOI
  93. 10.1016/S0006-8993(00)03108-5 · DOI · Paper page
  94. 10.1016/j.exger.2006.11.005 · DOI
  95. HarleyCB.LiuW.BlascoM.et al.A natural product telomerase activator as part of a health maintenance program.Rejuvenation Res. In press.
  96. 10.1001/jama.1983.03330250034024 · DOI · Paper page
  97. 10.1016/j.ceb.2010.04.011 · DOI
  98. 10.1016/j.ejphar.2007.12.032 · DOI · Paper page
  99. 10.1542/peds.65.4.862 · DOI

Cited by

See all 214

Metadata

Authors
M. Wolkowitz, O., I. Reus, V., & H. Mellon, S.
Venue
Dialogues in Clinical Neuroscience
Published
2011-03-31
Volume
13
Issue
1
Pages
25-39
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W1659146612
Cited by
214
References
59
FWCI
6.94
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.